Sanofi (SNY) to Stop Research in Diabetes, Cardiovascular Diseases, May Sell Regeneron (REGN) Stake - Reports

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. ACN
2. SPCX
3. NVDA
4. MSTR
5. MU
6. BAUFF
7. ICE
8. KR
9. APGE
10. ABBV

Go back to Sanofi (SNY) to Stop Research in Diabetes, Cardiovascular Diseases, May Sell Regeneron (REGN) Stake - Reports

Regeneron (REGN), Sanofi (SNY) Report Plans to Restructure Antibody Collaboration for Kevzara (sarilumab) and Praluent (alirocumab)

December 10, 2019 8:30 AM EST

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced their intent to simplify their antibody collaboration for Kevzara® (sarilumab)... More